Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for RDNT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 1998. Start Trial.
Date Value
December 31, 2025 298.82M
December 31, 2024 233.02M
December 31, 2023 220.86M
December 31, 2022 146.42M
December 31, 2021 149.49M
December 31, 2020 233.02M
December 31, 2019 104.32M
December 31, 2018 116.75M
December 31, 2017 143.70M
December 31, 2016 91.64M
December 31, 2015 67.04M
December 31, 2014 61.00M
December 31, 2013 66.42M
December 31, 2012 75.27M
Date Value
December 31, 2011 57.64M
December 31, 2010 66.88M
December 31, 2009 76.62M
December 31, 2008 45.20M
December 31, 2007 29.20M
December 31, 2006 0.725M
October 31, 2005 11.14M
October 31, 2004 17.05M
October 31, 2003 20.27M
October 31, 2002 13.70M
October 31, 2001 13.59M
October 31, 2000 8.107M
October 31, 1999 1.142M
October 31, 1998 -1.487M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Castle Biosciences, Inc. 64.35M
Lumexa Imaging Holdings, Inc. 17.07M
Quest Diagnostics, Inc. 1.886B
Labcorp Holdings, Inc. 1.640B
OPKO Health, Inc. -178.54M